Roles and therapeutic targeting of dendritic cells in liver fibrosis

References

• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6(1):425–456. doi: 10.1146/annurev-pathol-011110-130246.
   PubMedGoogle Scholar
• Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75(2):473–488. doi: 10.1002/hep.32285.
   PubMed Web of Science ®Google Scholar
• Manka P, Zeller A, Syn WK. Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities. Drugs. 2019;79(9):903–927. doi: 10.1007/s40265-019-01126-9.
   PubMed Web of Science ®Google Scholar
• Hsu W, Shu SA, Gershwin E, et al. The current immune function of hepatic dendritic cells. Cell Mol Immunol. 2007;4(5):321–328.
   PubMed Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42. doi: 10.1016/j.addr.2017.05.007.
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu F, He D, et al. Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10. Immunobiology. 2023;228(2):152315. doi: 10.1016/j.imbio.2022.152315.
   PubMed Web of Science ®Google Scholar
• Connolly MK, Ayo D, Malhotra A, et al. Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology. 2011;54(3):959–968. doi: 10.1002/hep.24429.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhou J, Zhang B, et al. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog. 2013;9(6):e1003410. doi: 10.1371/journal.ppat.1003410.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan D. Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis. J Cell Physiol. 2022;237(1):436–449. doi: 10.1002/jcp.30582.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tang X, Yang M, et al. Interleukin 10 gene-modified bone marrow-derived dendritic cells attenuate liver fibrosis in mice by inducing regulatory T cells and inhibiting the TGF-beta/smad signaling pathway. Mediators Inflamm. 2019;2019:4652596. (2019) doi: 10.1155/2019/4652596.
   PubMed Web of Science ®Google Scholar
• Evans TI, Li H, Schafer JL, et al. SIV-induced translocation of bacterial products in the liver mobilizes myeloid dendritic and natural killer cells associated with liver damage. J Infect Dis. 2016;213(3):361–369. doi: 10.1093/infdis/jiv404.
   PubMed Web of Science ®Google Scholar
• Yan M, Xie Y, Yao J, et al. The dual-mode transition of myofibroblasts derived from hepatic stellate cells in liver fibrosis. Int J Mol Sci. 2023;24(20):15460. doi: 10.3390/ijms242015460.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151–166. doi: 10.1038/s41575-020-00372-7.
   PubMed Web of Science ®Google Scholar
• Dewidar B, Meyer C, Dooley S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8(11):1419. doi: 10.3390/cells8111419.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu X, Zhang J, et al. Dynamic features of liver fibrogenesis and fibrosis resolution in the absence of matrix metalloproteinase‑9. Mol Med Rep. 2019;20(6):5239–5248.
   PubMed Web of Science ®Google Scholar
• Koda Y, Nakamoto N, Kanai T. Regulation of progression and resolution of liver fibrosis by immune cells. Semin Liver Dis. 2022;42(4):475–488. doi: 10.1055/a-1957-6384.
   PubMedGoogle Scholar
• Fasbender F, Widera A, Hengstler JG, et al. Natural killer cells and liver fibrosis. Front Immunol. 2016;7:19. doi: 10.3389/fimmu.2016.00019.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang S. T cells in fibrosis and fibrotic diseases. Front Immunol. 2020;11:1142. doi: 10.3389/fimmu.2020.01142.
   PubMed Web of Science ®Google Scholar
• Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633–646. doi: 10.1038/s41575-023-00807-x.
   PubMed Web of Science ®Google Scholar
• Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis. Int J Mol Sci. 2019;20(10):2507. doi: 10.3390/ijms20102507.
   PubMed Web of Science ®Google Scholar
• Ganguly N, Chakrabarti S. Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis. Int J Mol Med. 2021;47(3):04856. doi: 10.3892/ijmm.2021.4856.
   PubMed Web of Science ®Google Scholar
• Hou L-S, Zhang Y-W, Li H, et al. The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis. Pharmacol Ther. 2022;234:108117. doi: 10.1016/j.pharmthera.2022.108117.
   PubMed Web of Science ®Google Scholar
• Pan Q, Luo Y, Xia Q, et al. Ferroptosis and liver fibrosis. Int J Med Sci. 2021;18(15):3361–3366. doi: 10.7150/ijms.62903.
   PubMed Web of Science ®Google Scholar
• Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol. 2014;5:131. doi: 10.3389/fimmu.2014.00131.
   PubMed Web of Science ®Google Scholar
• Méndez-Sánchez N, Córdova-Gallardo J, Barranco-Fragoso B, et al. Hepatic dendritic cells in the development and progression of metabolic steatohepatitis. Front Immunol. 2021;12:641240. doi: 10.3389/fimmu.2021.641240.
   PubMed Web of Science ®Google Scholar
• Deczkowska A, David E, Ramadori P, et al. XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nat Med. 2021;27(6):1043–1054. doi: 10.1038/s41591-021-01344-3.
   PubMed Web of Science ®Google Scholar
• Roquilly A, Mintern JD, Villadangos JA. Spatiotemporal adaptations of macrophage and dendritic cell development and function. Annu Rev Immunol. 2022;40(1):525–557. doi: 10.1146/annurev-immunol-101320-031931.
   PubMedGoogle Scholar
• Albert ML, Decalf J, Pol S. Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C. J Hepatol. 2008;49(6):1069–1078. doi: 10.1016/j.jhep.2008.09.002.
   PubMed Web of Science ®Google Scholar
• Doyle EH, Rahman A, Aloman C, et al. Individual liver plasmacytoid dendritic cells are capable of producing IFNalpha and multiple additional cytokines during chronic HCV infection. PLoS Pathog. 2019;15(7):e1007935. doi: 10.1371/journal.ppat.1007935.
   PubMed Web of Science ®Google Scholar
• Chow KV, Sutherland RM, Zhan Y, et al. Heterogeneity, functional specialization and differentiation of monocyte-derived dendritic cells. Immunol Cell Biol. 2017;95(3):244–251. doi: 10.1038/icb.2016.104.
   PubMed Web of Science ®Google Scholar
• Menzner A-K, Rottmar T, Voelkl S, et al. Hydrogen-peroxide synthesis and LDL-uptake controls immunosuppressive properties in monocyte-derived dendritic cells. Cancers (Basel). 2021;13(3):461. doi: 10.3390/cancers13030461.
   PubMed Web of Science ®Google Scholar
• Lurje I, Hammerich L, Tacke F. Dendritic cell and T cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: implications for prevention and therapy of liver cancer. Int J Mol Sci. 2020;21(19):7378. doi: 10.3390/ijms21197378.
   PubMed Web of Science ®Google Scholar
• Ibrahim J, Nguyen AH, Rehman A, et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology. 2012;143(4):1061–1072. doi: 10.1053/j.gastro.2012.06.003.
   PubMed Web of Science ®Google Scholar
• Robertson H, Li J, Kim HJ, et al. Transcriptomic analysis identifies a tolerogenic dendritic cell signature. Front Immunol. 2021;12:733231. doi: 10.3389/fimmu.2021.733231.
   PubMed Web of Science ®Google Scholar
• Nakano R, Tran LM, Geller DA, et al. Dendritic cell-mediated regulation of liver ischemia-reperfusion injury and liver transplant rejection. Front Immunol. 2021;12:705465. doi: 10.3389/fimmu.2021.705465.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Ballesteros F, Morales-Reyes J, Fernández D, et al. Normal tissue homeostasis and impairment of selective inflammatory responses in dendritic cells deficient for ATF6alpha. Front Cell Dev Biol. 2023;11:1089728. doi: 10.3389/fcell.2023.1089728.
   PubMed Web of Science ®Google Scholar
• Cazzetta V, Franzese S, Carenza C, et al. Natural killer-dendritic cell interactions in liver cancer: implications for immunotherapy. Cancers (Basel). 2021;13(9):2184.). doi: 10.3390/cancers13092184.
   PubMed Web of Science ®Google Scholar
• Cardoso CC, Matiollo C, Pereira CHJ, et al. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients. Sci Rep. 2021;11(1):5923. doi: 10.1038/s41598-021-85148-y.
   PubMed Web of Science ®Google Scholar
• Wan M, Han J, Ding L, et al. Novel immune subsets and related cytokines: emerging players in the progression of liver fibrosis. Front Med (Lausanne). 2021;8:604894. doi: 10.3389/fmed.2021.604894.
   PubMed Web of Science ®Google Scholar
• Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37–55. doi: 10.1016/j.mam.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Wree A, McGeough MD, Inzaugarat ME, et al. NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice. Hepatology. 2018;67(2):736–749. doi: 10.1002/hep.29523.
   PubMed Web of Science ®Google Scholar
• Bamboat ZM, Ocuin LM, Balachandran VP, et al. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest. 2010;120(2):559–569. doi: 10.1172/JCI40008.
   PubMed Web of Science ®Google Scholar
• Pradere J-P, Kluwe J, De Minicis S, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58(4):1461–1473. doi: 10.1002/hep.26429.
   PubMed Web of Science ®Google Scholar
• Chu X, Jin Q, Chen H, et al. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. J Transl Med. 2018;16(1):108. doi: 10.1186/s12967-018-1490-y.
   PubMedGoogle Scholar
• Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol. 2011;2011:345803. doi: 10.1155/2011/345803.
   PubMedGoogle Scholar
• Wu K-J, Qian Q-F, Zhou J-R, et al. Regulatory T cells (tregs) in liver fibrosis. Cell Death Discov. 2023;9(1):53. doi: 10.1038/s41420-023-01347-8.
   PubMed Web of Science ®Google Scholar
• Mo C, Xie S, Liu B, et al. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death Dis. 2021;12(1):16. doi: 10.1038/s41419-020-03277-0.
   PubMed Web of Science ®Google Scholar
• Bleier JI, Katz SC, Chaudhry UI, et al. Biliary obstruction selectively expands and activates liver myeloid dendritic cells. J Immunol. 2006;176(12):7189–7195. doi: 10.4049/jimmunol.176.12.7189.
   PubMed Web of Science ®Google Scholar
• Higashitani K, Kanto T, Kuroda S, et al. Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J Gastroenterol. 2013;48(5):660–670. doi: 10.1007/s00535-012-0667-z.
   PubMed Web of Science ®Google Scholar
• Wei Y, Bingyu W, Lei Y, et al. The antifibrotic role of natural killer cells in liver fibrosis. Exp Biol Med (Maywood). 2022;247(14):1235–1243. doi: 10.1177/15353702221092672.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu Y, Shen W, et al. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (review. Mol Med Rep. 2022;25(6):208.) doi: 10.3892/mmr.2022.12724.
   PubMed Web of Science ®Google Scholar
• Yang M, Vanderwert E, Kimchi ET, et al. The important roles of natural killer cells in liver fibrosis. Biomedicines. 2023;11(5):1391. doi: 10.3390/biomedicines11051391.
   PubMed Web of Science ®Google Scholar
• Connolly MK, Bedrosian AS, Mallen-St Clair J, et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest. 2009;119(11):3213–3225. doi: 10.1172/JCI37581.
   PubMed Web of Science ®Google Scholar
• Cheng D, Chai J, Wang H, et al. Hepatic macrophages: key players in the development and progression of liver fibrosis. Liver Int. 2021;41(10):2279–2294. doi: 10.1111/liv.14940.
   PubMed Web of Science ®Google Scholar
• Ananiev J, Penkova M, Tchernev G, et al. Macrophages and dendritic cells in the development of liver injury leading to liver failure. J Biol Regul Homeost Agents. 2014;28(4):789–794.
   PubMed Web of Science ®Google Scholar
• Tanoue S, Chang LY, Li Y, et al. Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects. Cell Immunol. 2015;295(1):36–45. doi: 10.1016/j.cellimm.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Heier E-C, Meier A, Julich-Haertel H, et al. Murine CD103(+) dendritic cells protect against steatosis progression towards steatohepatitis. J Hepatol. 2017;66(6):1241–1250. doi: 10.1016/j.jhep.2017.01.008.
   PubMed Web of Science ®Google Scholar
• Blois SM, Piccioni F, Freitag N, et al. Dendritic cells regulate angiogenesis associated with liver fibrogenesis. Angiogenesis. 2014;17(1):119–128. doi: 10.1007/s10456-013-9382-5.
   PubMed Web of Science ®Google Scholar
• Jiao J, Sastre D, Fiel MI, et al. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology. 2012;55(1):244–255. doi: 10.1002/hep.24621.
   PubMed Web of Science ®Google Scholar
• Kakazu E, Kanno N, Ueno Y, et al. Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol. 2007;179(10):7137–7146. doi: 10.4049/jimmunol.179.10.7137.
   PubMed Web of Science ®Google Scholar
• Duan XZ, Wang M, Li HW, et al. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol. 2004;24(6):637–646. doi: 10.1007/s10875-004-6249-y.
   PubMed Web of Science ®Google Scholar
• Laso FJ, Vaquero JM, Almeida J, et al. Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res. 2007;31(5):846–854. doi: 10.1111/j.1530-0277.2007.00377.x.
   PubMed Web of Science ®Google Scholar
• Sutti S, Locatelli I, Bruzzì S, et al. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. Clin Sci (Lond). 2015;129(9):797–808. doi: 10.1042/CS20150053.
   PubMed Web of Science ®Google Scholar
• Sehgal M, Zeremski M, Talal AH, et al. IFN-alpha-induced downregulation of miR-221 in dendritic cells: implications for HCV pathogenesis and treatment. J Interferon Cytokine Res. 2015;35(9):698–709. doi: 10.1089/jir.2014.0211.
   PubMed Web of Science ®Google Scholar
• Friedman SL, Sheppard D, Duffield JS, et al. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5(167):167sr1. 167sr161. doi: 10.1126/scitranslmed.3004700.
   PubMed Web of Science ®Google Scholar
• Beckebaum S, Cicinnati VR, Zhang X, et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology. 2003;109(4):487–495. doi: 10.1046/j.1365-2567.2003.01699.x.
   PubMed Web of Science ®Google Scholar
• Xiang M, Liu T, Tian C, et al. Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway. Pharmacol Res. 2022;177:106092. doi: 10.1016/j.phrs.2022.106092.
   PubMed Web of Science ®Google Scholar